selected publications
-
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Cancer discovery.
2020
Academic Article
GET IT
Times cited: 100 -
Optimizing immunotherapy for gynecologic cancers.
Current opinion in obstetrics & gynecology.
2020
Review
GET IT
Times cited: 20 -
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Cancer.
2019
Academic Article
GET IT
Times cited: 30 -
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
International journal of cancer.
2019
Academic Article
GET IT
Times cited: 27 -
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 25 -
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Comment
GET IT
Times cited: 33 -
Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Brachytherapy.
2018
Academic Article
GET IT
Times cited: 7 -
Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 12 -
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 49 -
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2018
Academic Article
GET IT
Times cited: 5 -
Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report.
2018
GET IT
Times cited: 2086 -
Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.
2018
GET IT
Times cited: 6 - New therapies for advanced, recurrent, and metastatic endometrial cancers. Gynecologic oncology research and practice. 2017 Review GET IT
- Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12]. Gynecologic oncology reports. 2017 Academic Article GET IT
-
Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation.
2017
GET IT
Times cited: 2 -
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Investigational new drugs.
2017
Academic Article
GET IT
Times cited: 10 -
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Annals of surgical oncology.
2017
Academic Article
GET IT
Times cited: 46 -
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Cancer.
2016
Academic Article
GET IT
Times cited: 52 -
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 17 - Nonbacterial thrombotic endocarditis with embolic cerebral vascular accidents in a patient with advanced, recurrent clear cell carcinoma of the ovary: A case report. 2016 GET IT
-
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2016
Academic Article
GET IT
Times cited: 11 -
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.
2015
GET IT
Times cited: 76 -
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping.
Annals of surgical oncology.
2015
Academic Article
GET IT
Times cited: 76 -
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Gynecologic oncology.
2015
Academic Article
GET IT
Times cited: 29 -
Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 23 -
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 91 -
Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2013
Academic Article
GET IT
Times cited: 3 -
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
Gynecologic oncology.
2013
Academic Article
GET IT
Times cited: 61 -
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.
Gynecologic oncology.
2013
Academic Article
GET IT
Times cited: 26 -
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2013
Academic Article
GET IT
Times cited: 35 -
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2013
Academic Article
GET IT
Times cited: 9 -
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
Radiation oncology (London, England).
2013
Academic Article
GET IT
Times cited: 18 -
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 55 -
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 53 -
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 37 -
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 55 -
Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
Gynecologic oncology.
2008
Academic Article
GET IT
Times cited: 36 -
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
Gynecologic oncology.
2008
Academic Article
GET IT
Times cited: 62